Omnia Molecular
Designs and develops anti-infectives targeted at difficult-to-treat infections.
| Date | Investors | Amount | Round |
|---|---|---|---|
N/A | Spinout | ||
€640k | Grant | ||
| Total Funding | €640k | ||
Related Content
Recent News about Omnia Molecular
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.